Target intelligence / Profile preview

Leucine-rich repeat-containing protein 72 (LRRC72)

Target
LRRC72
Molecular classification
Leucine-rich repeat protein, Protein with tandem repeat domain, Other
01

Overview

Leucine-rich repeat-containing protein 72 is a member of the leucine-rich repeat (LRR) superfamily of proteins characterized by tandem repeats containing conserved leucine residues. LRR domains function as versatile scaffolds enabling protein-protein interactions often involved in processes such as immune signaling, cell adhesion, neurodevelopment, and structural support. LRRC72 is a protein coding gene with limited functional annotation. Its expression has been associated with certain genetic conditions, including primary ciliary dyskinesia, but its biological role remains largely uncharacterized. LRRC72 is not currently known to serve as a receptor, enzyme, or transporter, and there are no drugs nor biomarkers associated with it. Most functional insights for LRR-containing proteins are derived from other family members, many of which play roles in innate immunity, cell signaling, or cytoskeletal organization. LRRC72 appears to be an "LRR-only" protein without additional annotated functional domains—this limits functional inference. There is no evidence in current literature of LRRC72 being a validated therapeutic target, clinical biomarker, or target of pharmacological agents. In summary: LRRC72 is a protein with leucine-rich repeats and limited known function. It is not a designated therapeutic target, is not misspelled, and lacks robust disease or drug associations as of current data.

Other names
CFAP279FAP279ENSP00000371558Leucine-rich repeat-containing protein 72LRRC72
02

Biological functions

Protein-protein interactions (general to LRR proteins)Structural scaffolding (general to LRR proteins)Other (no specific function characterized for LRRC72)
03

Disease associations

Primary ciliary dyskinesia association (limited data; reported in gene-disease association databases)Other/unknown (no strong evidence for major disease involvement)

Beyond the preview

Go deeper on Leucine-rich repeat-containing protein 72 (LRRC72).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat-containing protein 72 (LRRC72).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call